← Leaderboards
Maria Serena Longhi
Beth Israel Deaconess Medical Center
$3,119,696
Attributed
$3,119,696
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $774.7K · FY2017–22$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,119,696 · 2
By mechanism
R01$3,119,696 · 2
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Barbara Wegiel$4,886,655
Others in their field
Other Emerging Leaders on “Hypoxia Inducible Factor 1”
- Bing Yao · Emory University$3,941,624
- Abeer M Mohamed · University Of Illinois At Chicago$3,775,395
- Pinelopi P. Kapitsinou · University Of Kansas Medical Center$3,632,107
- Fnu Kshitiz · University Of Connecticut Sch Of Med/Dnt$2,981,392
- Claudio Scafoglio · University Of California Los Angeles$2,825,956
- Giovanni Ligresti · Mayo Clinic Rochester$2,782,716
Research focus
Hypoxia Inducible Factor 1ImpairmentExposure ToHemeImmuneImmunoregulationDisease ProgressionEquilibriumExtracellularGenerationsIcterusAryl Hydrocarbon Receptor LigandImmune ResponseCellsChronicCatabolismApyraseEffector CellArnt GeneBilirubinBiliverdineAdenosineAryl Hydrocarbon ReceptorInflammation
Grant awards (8)
Alterations of aryl hydrocarbon receptor signaling in autoimmune hepatitis$385,000
R01 · FY2022 · DK · contact PI
Immunomodulatory effects of bilirubin are mediated through aryl hydrocarbon receptor, O2 and purinergic pathways$389,671
R01 · FY2021 · DK · contact PI
Alterations of aryl hydrocarbon receptor signaling in autoimmune hepatitis$385,000
R01 · FY2021 · DK · contact PI
Immunomodulatory effects of bilirubin are mediated through aryl hydrocarbon receptor, O2 and purinergic pathways$389,662
R01 · FY2020 · DK · contact PI
Alterations of aryl hydrocarbon receptor signaling in autoimmune hepatitis$385,000
R01 · FY2020 · DK · contact PI
Immunomodulatory effects of bilirubin are mediated through aryl hydrocarbon receptor, O2 and purinergic pathways$389,654
R01 · FY2019 · DK · contact PI
Immunomodulatory effects of bilirubin are mediated through aryl hydrocarbon receptor, O2 and purinergic pathways$394,889
R01 · FY2018 · DK · contact PI
Immunomodulatory effects of bilirubin are mediated through aryl hydrocarbon receptor, O2 and purinergic pathways$400,820
R01 · FY2017 · DK · contact PI